These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36801944)

  • 1. Quantitative Analysis of Lysergic Acid Diethylamide and Metabolite in Urine by Automated Extraction and Liquid Chromatography-Tandem Mass Spectrometry.
    Patton AL; Brown J; Heine K; Sartori DA; Karschner EL; Walterscheid JP
    J Anal Toxicol; 2023 May; 47(5):448-454. PubMed ID: 36801944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.
    Jang M; Kim J; Han I; Yang W
    J Pharm Biomed Anal; 2015 Nov; 115():138-43. PubMed ID: 26188861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
    Dolder PC; Liechti ME; Rentsch KM
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens.
    Reuschel SA; Eades D; Foltz RL
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):145-59. PubMed ID: 10572980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.
    Steuer AE; Poetzsch M; Stock L; Eisenbeiss L; Schmid Y; Liechti ME; Kraemer T
    Drug Test Anal; 2017 May; 9(5):788-797. PubMed ID: 27422082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
    de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
    J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.
    Poch GK; Klette KL; Anderson C
    J Anal Toxicol; 2000 Apr; 24(3):170-9. PubMed ID: 10774536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine.
    Chung A; Hudson J; McKay G
    J Anal Toxicol; 2009 Jun; 33(5):253-9. PubMed ID: 19671244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
    Dolder PC; Liechti ME; Rentsch KM
    Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluids.
    Nelson CC; Foltz RL
    J Chromatogr; 1992 Sep; 580(1-2):97-109. PubMed ID: 1400834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
    Sklerov JH; Magluilo J; Shannon KK; Smith ML
    J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity method for the determination of LSD and 2-oxo-3-hydroxy-LSD in oral fluid by liquid chromatography‒tandem mass spectrometry.
    da Cunha KF; Kahl JMM; Fiorentin TR; Oliveira KD; Costa JL
    Forensic Toxicol; 2022 Jul; 40(2):322-331. PubMed ID: 36454414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
    Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL
    J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of lysergic acid diethylamide (LSD), iso-LSD, and N-demethyl-LSD in body fluids by gas chromatography/tandem mass spectrometry.
    Nelson CC; Foltz RL
    Anal Chem; 1992 Jul; 64(14):1578-85. PubMed ID: 1503225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M; Johansen SS; Thomsen R; Linnet K
    Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of psilocin, bufotenine and LSD in hair.
    Martin R; Schürenkamp J; Gasse A; Pfeiffer H; Köhler H
    J Anal Toxicol; 2015 Mar; 39(2):126-9. PubMed ID: 25540060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
    Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
    J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
    Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
    Johansen SS; Jensen JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):21-8. PubMed ID: 16154519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of lysergic acid diethylamide in body fluids by high-performance liquid chromatography and fluorescence detection--a more sensitive method suitable for routine use.
    Bergemann D; Geier A; von Meyer L
    J Forensic Sci; 1999 Mar; 44(2):372-4. PubMed ID: 10097365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.